Globally Marketed Products

  • ANGIOX® (bivalirudin) is approved in Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece,  Iceland, Ireland, Italy, Kazakhstan, Luxembourg, Netherlands, Norway, Poland, Portugal, Russia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom.
  • ANGIOMAX® (bivalirudin) is approved in Argentina, Australia, Canada, Chile, India, Israel, New Zealand, Peru and Venezuela.
  • In the European Union, we have marketing approval for IONSYS® (fentanyl iontophoretic transdermal system).
  • Approved product indications, registrations, and presentations may differ between countries. Therefore, please  Global Medical Information or appropriate regional office to obtain the most current registration details and approved product label.

Global Medical Information

Approved product indications, registrations, and presentations may differ between countries. Therefore, please the Global Medical Information or appropriate regional office to obtain the most current registration details and approved product label.